AMENDMENT TO INCLUDE RESEARCH ON THE CO-OCCURRENCE AND HEALTHCONSEQUENCES OF VIOLENCE, DRUG ABUSE, AND HIV/AIDS NIH GUIDE, Volume 25, Number 6, March 1, 1996 PA NUMBER: PA-95-072, International Epidemiology Research on Drug Abuse PA-95-060, Drug and Alcohol Use and Abuse in Rural America PA-95-059, Local Population/Area Epidemiologic Drug Research PA-95-057, HIV Risk Behaviors, Determinants and Consequences PA-94-054, Strategies to Reduce HIV Sexual Risk Practices PA-94-010, Needle Hygiene & Needle Exchange Program Research PA-94-007, Survey Research on Drug Use/Associated Behaviors PA-93-111, Partner Notification to HIV-Infected Drug Users PA-93-046, Drug Abuse in Minority & Underserved Populations P.T. 34 Keywords: AIDS Drugs/Drug Abuse Violent Behavior Behavioral/Social Studies/Service National Institute on Drug Abuse PURPOSE For those investigators applying for new grants or competing supplements under the program of research sponsored by the National Institute on Drug Abuse (NIDA) Community Research Branch, this notice is meant to amend Program Announcements PA-95-072 (NIH Guide, Vol. 24, No. 2, June 16, 1995), PA-95-060 (NIH Guide, Vol. 24, No. 16, May 12, 1995), PA-95-059 (NIH Guide, Vol. 24, No. 15, May 5, 1995), PA-95-057 (NIH Guide, Vol. 24, No. 16, May 5, 1995), PA-94-054 (NIH Guide, Vol. 23, No. 14, April 8, 1994), PA-94-010 (NIH Guide, Vol. 22, No. 40, November 5, 1993), PA-94-007 (NIH Guide, Vol. 22, No. 39, October 29, 1993), PA-93-111 (NIH Guide, Vol. 22, No. 33, September 17, 1993), and PA-93-046 (NIH Guide, Vol. 22, No. 5, February 5, 1993), which are still in effect and should be consulted in conjunction with this amendment. (Research on violence has already been requested under PA-95-083, "Women's HIV Risk and Protective Behaviors.") The referenced PAs address rural-, local area-, and international epidemiologies of drug abuse, including enhanced survey research on drug use issues; the patterns, causes and consequences of drug use among minority or underserved populations; the epidemiologies of drug abuse and HIV/AIDS; and interventions to reduce behaviors linked to the transmission of HIV among drug users and their sex partners. This addendum focuses on the co-occurrence, interrelatedness, and health consequences of three major public health problems: drug abuse, violence, and HIV/AIDS. To this end, NIDA will support the following kinds of studies: (1) local-level community epidemiology studies to document and monitor trends in the nature, extent, and patterns of co-occurring drug use, violence, and HIV/AIDS, as well as their negative health consequences; (2) studies of the common and unique risk/protective antecedents and correlates of these phenomena; (3) studies of reciprocal linkages among drug use, violence, and HIV risk taking (e.g., the effect of drug use on sexual assault or other HIV risks; the effect of sexual assault or coercion on HIV infection; the effect of sexual risk-taking on drug use); (4) studies that design, implement and evaluate interventions to reduce/prevent drug-related violence and HIV risk behaviors and their negative health consequences; and (5) methodological studies to improve the measurement, data collection, and analysis of drug-related violence and HIV behaviors, or to extend prevailing research paradigms thereon. In contrast, this addendum will not support research focusing exclusively on the criminal behavior/criminal justice outcomes of drug abuse. Populations of concern include high-risk male and female drug injectors and non-injectors from urban and rural communities as well as subgroups of the population that are disproportionately at risk for drug abuse, violence, and HIV/AIDS. Applications must be submitted on the grant application form PHS 398 (rev. 5/95) using the receipt dates outlined in the PHS 398 kit. INQUIRIES Direct inquiries regarding programmatic issues to: Richard Needle, Ph.D., M.P.H. or Susan Coyle, Ph.D. Division of Epidemiology and Prevention Research National Institute on Drug Abuse 5600 Fishers Lane, Room 9A-42 Rockville, MD 20857 Telephone: (301) 443-6720 FAX: (301) 443-2636 Email: RNEEDLE@AOADA.SSW.DHHS.GOV or SCOYLE@AOADA.SSW.DHHS.GOV .
Return to NIH Guide Main Index
Office of Extramural Research (OER) |
National Institutes of Health (NIH) 9000 Rockville Pike Bethesda, Maryland 20892 |
Department of Health and Human Services (HHS) |
||||||||
Note: For help accessing PDF, RTF, MS Word, Excel, PowerPoint, Audio or Video files, see Help Downloading Files. |